Sustained disease control with aflibercept 8 mg: a new benchmark in the management of retinal neovascular diseases

Affiliations

• ¹ CHU Bordeaux, Service d'ophtalmologie, Bordeaux, France.
• ² University of Bordeaux, INSERM, BPH, UMR1219, Bordeaux, France.
• ³ Department of Medicine - Ophthalmology, University of Udine, and Istituto Europeo di Microchirurgia Oculare - IEMO, Udine, Italy.
• ⁴ Retina Consultants of Texas, Retina Consultants of America, Blanton Eye Institute, Houston Methodist Hospital, Houston, TX, USA.
• ⁵ Singapore Eye Research Institute, Singapore National Eye Centre, Singapore, Singapore.
• ⁶ Tsinghua Medicine, Tsinghua University, Beijing, China.
• ⁷ Bayer Consumer Care AG, Basel, Switzerland.
• ⁸ Bayer Inc., Mississauga, Ontario, Canada.
• ⁹ Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.
• ¹⁰ NIHR Moorfields Biomedical Research Centre, Moorfields Eye Hospital NHS Foundation Trust, London, UK. [email protected].